Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
Surgical oncology is the branch of surgery applied to oncology it focuses on the surgical management of tumours , especially cancerous tumors.
OMICS International organised 46 Conferences/Workshops, 45 Symposium, 2 Papers Published, with 34 Speakers till date .
OMICS International Organizes 300+ conferences, 500+workshops and 200+symposiums on Clinical, Medicine, Pharma, Science & Technology every year across USA, Europe, Asia, Middle East, Australia and UK with support from 1000 more Scientific Societies and Publishes 500 open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. The OMICS International Conferences are instrumental in giving a serious stage to the incredibly famous scientists, understudies, researchers, academicians, organizations, business visionaries and businesses through its 300+ International Conferences and occasions yearly all through the globe to raise and examine the advancements in the field of OMICS Study. OMICS International Conferences are completely pressed with intriguing occasions, exercises and learning going with the quick entrepreneurial enthusiasm to make them genuine. They are multidimensional with synchronous movement situated symposia, International workshops and presentations where the identities from Sciences (Both unadulterated & connected), Pharmaceutical, Medical, Clinical, Engineering & Technology and Life Sciences accumulate with their procedures in discovering genuine answers for different basic issues around the globe.
Scope & Importance
Surgical oncology is a very research-focussed specialty. Clinical oncology consists of three primary disciplines: medical oncology (the treatment of cancer with medicine, including chemotherapy), surgical oncology (the surgical aspects of cancer including biopsy, staging, and surgical resection of tumors), and radiation oncology (the treatment of cancer with therapeutic radiation).
Surgical Oncology is concerned with:
·The diagnosis/ Screening of any cancer in a person (pathology)
.Therapy (e.g. surgery, chemotherapy, radiotherapy and other modalities)
·Follow-up of cancer patients after successful treatment
·Palliative care of patients with terminal malignancies
·Ethical questions surrounding cancer care
Surgical oncology is a major participant in any multi-disciplinary team (MDT), which would meet regularly to discuss site specific cases of tumours. Other members would be site specific surgeon, palliative care physician, radiologist, pathologist, specialist nursing staff and appropriate haematologist and medical oncologist.
Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia).
The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. The biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.
Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period.
List of International Conferences on Oncology
List of major Associations and Societies on Oncology
List of Key Companies
This page will be updated regularly.
This page was last updated on November 29, 2022